Canterbury DHB

Context

Introduction

Allo-antibodies to factor VIII occur in 10 - 15% of patients with classical haemophilia (usually <10% FVIII level) and usually within the first 40 treatment exposure days. Inhibitors do not occur after 200 treatment exposure days. Factor IX antibodies are extremely rare.

Information Required

About this Canterbury DHB document (5268):

Document Owner:

Mark Smith (see Who's Who)

Issue Date:

August 2016

Next Review:

August 2019

Keywords:

Note: Only the electronic version is controlled. Once printed, this is no longer a controlled document. Disclaimer

Topic Code: 5268